New Study First to Confirm Sandostatin LAR(R) Depot Controls Tumor Growth in Patients With Rare Gastrointesti...(s and societies. Focused solely on healt...),Health

Date:1/13/2009

s and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs, innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group's continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 97,000 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

References

(1). Arnold et al Clin Gastro Hepatol 2005; Saltz et al. Cancer 1993; Arnold et al. Gut 1996; Di Bartolomeo et al Cancer 1996

    Novartis Media Relations

    Media only:

    Denise Brashear
    Novartis Oncology
    P: +1 862 778 7336
    M: +1 917 453 2665

    Dana Kahn Cooper
    P: +1 732 817 1800
    F: +1 732 817 1834
    e-mail: media.relations@novartis.com

    Investors only:

    Jill Pozarek
    Novartis Corporation
    P: +1 212 830 2445

'/>"/>

SOURCE Novartis Pharmaceuticals Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. VA-NIH Study Offers Hope for Parkinsons Patients
2. Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence
3. Reproductive Partners Participates in New IVF Progesterone Delivery System Study
4. Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
5. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
6. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
7. ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers
8. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
9. Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer
10. Major deCODE-led Study Underscores Role of the Brain in Obesity
11. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)